Aker Biomarine AS (AKBM) — Capital Reinvestment Ratio
Latest as of December 2024:
1.70x
Aker Biomarine AS (AKBM) has a Capital Reinvestment Ratio of 1.70x as of December 2024, meaning it reinvests 2% of its operating cash flow (Nkr7.60 Million) in capital expenditures (Nkr12.90 Million). See Aker Biomarine AS free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.70x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr7.60 Million
NOK
Capital Expenditures
Nkr12.90 Million
NOK
Data as of
Dec 2024
Most recent filing
Aker Biomarine AS Capital Reinvestment Ratio (2016–2024)
This chart tracks Aker Biomarine AS's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Aker Biomarine AS (2016–2024)
Year-by-year Capital Reinvestment Ratio for Aker Biomarine AS from 2016 to 2024. For live market cap and broader valuation context, see AKBM market cap.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.89x | Nkr12.20 Million | Nkr23.10 Million | ▲ +82.0% |
| 2023 | 1.04x | Nkr47.40 Million | Nkr49.30 Million | ▼ -65.9% |
| 2022 | 3.05x | Nkr15.10 Million | Nkr46.10 Million | ▼ -97.3% |
| 2021 | 111.26x | Nkr729.00K | Nkr81.11 Million | ▲ +978.9% |
| 2019 | 10.31x | Nkr12.31 Million | Nkr126.92 Million | ▲ +26.2% |
| 2018 | 8.17x | Nkr7.89 Million | Nkr64.51 Million | ▼ -32.6% |
| 2017 | 12.12x | Nkr9.17 Million | Nkr111.20 Million | ▲ +2222.5% |
| 2016 | 0.52x | Nkr20.88 Million | Nkr10.90 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow